ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,498, issued on May 20, was assigned to CYTOO (Grenoble, France).
"ALK5 inhibitors as skeletal muscle hypertrophy inducers" was invented by Pauline Poydenot (Novalaise, France), Joris Michaud (Lausanne, Switzerland), Melanie Flaender (Grenoble, France), Eve Duchemin-Pelletier (Vizille, France) and Luc Selig (Charenton le Pont, France).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to ALK5 inhibitors and their uses as skeletal muscle hypertrophy inducers as well as to promote skeletal muscle regeneration, to prevent skeletal muscle atrophy, or in the treatment or prevention of a disease or injury resulting in loss of skele...